Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients

BACKGROUND: Glatiramer acetate (GA) is a mixture of synthetic peptides used in the treatment of patients with relapsing-remitting multiple sclerosis (RRMS). The aim of this study was to investigate the effects of GA therapy on the gene expression of monocytes. METHODS: Monocytes were isolated from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Thamilarasan, Madhan, Hecker, Michael, Goertsches, Robert Hermann, Paap, Brigitte Katrin, Schröder, Ina, Koczan, Dirk, Thiesen, Hans-Jürgen, Zettl, Uwe Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852967/
https://www.ncbi.nlm.nih.gov/pubmed/24134771
http://dx.doi.org/10.1186/1742-2094-10-126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852967/
https://www.ncbi.nlm.nih.gov/pubmed/24134771
http://dx.doi.org/10.1186/1742-2094-10-126

Ejemplares similares